Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21

Impact of COVID-19 pandemic on influenza vaccination rates among healthcare workers and the general population in Saudi Arabia: A meta-analysis

We aim to identify how the seasonal IVRs have been impacted by the COVID-19 pandemic in Saudi Arabia. We conducted a meta-analysis of cross-sectional studies to statistically examine IVRs before and after the COVID-19 pandemic among the general population and HCWs in Saudi Arabia. The meta-regression analysis showed a significant correlation among the general population was observed between the IVR and the timing of the study, with a mean effect size estimate of 14.3 (95% CI = 5.7-22.9; p < .001). Among HCWs, no significant relationship was observed between the IVR and the timing of the study, with a mean effect size estimate of 6.7 (95% CI = -19.3-32.7; p = .5). COVID-19 might have contributed to a rise in IVR among HCWs, whereas the general population has seen a decline in IVR.

Vaccination readiness among adults in Norway: A cross-sectional survey using the 7C model

BACKGROUND

Maintaining high vaccination readiness is key to sustaining high vaccination coverage. In this study, we aim to estimate the vaccination readiness of the Norwegian adult population and explore its associations with sociodemographic characteristics and the intention to be vaccinated.

METHODS

A representative sample of the adult Norwegian population were surveyed with the validated 7C questionnaire on general vaccination readiness, which contains items about seven components of vaccination readiness (confidence, complacency, constraints, calculation, collective responsibility, compliance and conspiracy). Participants were also asked about sociodemographic background and their intention to be vaccinated against COVID-19 and influenza. We assessed associations involving vaccination readiness in linear and logistic regression models.

RESULTS

A total of 4137 individuals participated in the survey (overall response rate 50.5 %). Our study sample was comparable to the Norwegian population in terms of sociodemographic characteristics. On a scale from 1 to 7, the mean overall 7C vaccination readiness score was 4.82. Low overall vaccination readiness was associated with sociodemographic characteristics such as male sex, younger age, low education, low income and living alone. Overall vaccination readiness was strongly associated with intention to receive a booster dose of COVID-19 vaccine among those aged 18 years or older (adjusted odds ratio (aOR) 10.23, 95 % confidence interval (95 %CI) 8.38 to 12.49)), and with influenza vaccination among those aged 65 years or older (aOR 7.38, 95 %CI 4.51 to 12.10)), as were each of the seven vaccination readiness components when regressed on vaccination intention.

CONCLUSION

Overall general vaccination readiness was relatively high in the adult population in Norway. However, it differed between sociodemographic groups. Component and overall vaccination readiness scores were associated with intention to be vaccinated, and these associations were stronger for booster vaccination against COVID-19 than against influenza. The observed 7C estimates enable tracking of vaccination readiness over time and help identify themes and populations that can be targeted to improve compliance with vaccination program recommendations.

Drivers and barriers of seasonal influenza vaccination 2015/16 & 2019/20 to 2022/23 - a survey on why most Norwegians don't get the flu vaccine

BACKGROUND

This study aimed to explore the reasons adults in the general population, influenza risk groups (RGs) and health care workers (HCWs) in Norway give for their vaccination choices and whether these reasons vary between groups or over time in order to further improve influenza vaccination coverage.

METHODS

Respondents of a nationally representative telephone survey conducted by Statistics Norway were asked "What was the most important reason why you did/did not get vaccinated?". The question on influenza non-vaccination was included in 2016 and in 2020 to 2023 and the question on influenza vaccination in 2021 to 2023.

RESULTS

The study included 9 705 individuals aged 18-79 years. Influenza vaccination coverage in the RGs increased from 20.6% in 2016 to 63.1% in 2022, before a reduction to 58.3% in 2023. Common reasons for non-vaccination were similar in all groups. The most cited reasons were "no need" for the vaccine and "no specific reason", followed by "not recommended/offered the vaccine", "worry about side effects" and "vaccine refusal". The most frequent reasons for vaccination among the general population and RGs were protection against influenza and belonging to a RG, while the most frequent responses among HCWs were being offered the vaccine at work/work in health care, followed by a desire for protection against influenza. Receiving a vaccine recommendation from a health professional was mentioned in all groups. We also observed that the proportion reporting "no need" for the vaccine decreased over time, especially among HCWs, and that the proportions reporting vaccine refusal and worry about side effects as reasons for non-vaccination were temporarily reduced during the COVID-19 pandemic.

CONCLUSIONS

The general population and RGs cite protection against influenza as their primary incentive for vaccination, while HCWs mainly refer to their professional role or workplace vaccination. For non-vaccination we see a similar pattern in all groups, with "no need" and "no specific reason" as the main reasons. Of note, worry about side effects and vaccine refusal is as frequent among HCWs as in other groups. Continued efforts to maintain and increase vaccine confidence are needed.

Higher educational attainment associated with higher confidence in influenza vaccination in Norway

AIMS

To explore public confidence in influenza vaccination through the use of attitudinal indicators, and study whether educational attainment is related to attitudes towards influenza vaccination.

METHODS

Confidence in influenza vaccination was measured with three questions adapted from the Vaccine Confidence Project. These questions have been included in four study years of a Norwegian nationally representative telephone survey that cover influenza seasons 2016/17, 2019/20, 2020/21 and 2021/22. Over these four years, a total of 8 436 individuals aged 18-79 years responded to the survey and are included in the analysis. Risk differences (RDs) with 95 % confidence intervals were estimated using multivariable Poisson regression.

RESULTS

Influenza vaccine confidence increased over time, with approximately 80 % of the general population expressing trust in the vaccine in the 2021/22 season. There was a tendency towards higher confidence in the oldest age group (65-79 years). Moreover, confidence increased with increasing educational attainment. The proportion of participants who agreed that influenza vaccine is compatible with their basic values was close to 20 percentage points lower among those with only compulsory education than among those with higher education at graduate level, RD = -18.4 % (95 % CI -21.4 % to -15.5 %). Educational attainment was consistently associated with influenza vaccine confidence in all seasons, among risk groups 18-64 years, and among health care workers.

CONCLUSIONS

We observed an increase in confidence in influenza vaccination over the seasons examined in the study. However, the increase has not been equal in all groups and there is a clear educational gradient in influenza vaccine confidence. These findings indicate that despite efforts to increase influenza coverage over several years, the implemented measures have failed to reach all parts of the population.

Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: a systematic review and meta-analysis

INTRODUCTION

Influenza immunization policies in Europe primarily target at-risk and vulnerable subjects. Healthcare workers (HCWs) are a key focus of vaccination campaigns. Our systematic review and meta-analysis aim to evaluate the role of the COVID-19 pandemic on influenza vaccine uptake among HCWs since the 2020/21 influenza season.

AREAS COVERED

Fourteen studies were included in the meta-analysis and systematic review, selected from scientific articles available in MEDLINE/PubMed, ISI Web of Knowledge, and Scopus databases between 1 January 2021 and 15 January 2023 The analysis revealed a significant relationship between influenza vaccine uptake and COVID-19 related determinants, such as willingness to receive COVID-19 vaccination, fear of COVID-19, and differentiating between influenza and COVID-19 symptoms (OR = 5.70; 95%CI = 2.08-15.60). Several studies reported higher vaccination coverages in the 2020/21 season compared to previous seasons, with VC values ranging from + 17% to + 38% compared to the 2019/20 season. The included studies identified a shift in HCWs' attitudes toward influenza vaccination, attributed to increased awareness due to the COVID-19 pandemic.

EXPERT OPINION

Vaccine hesitancy is common among HCWs in Europe, necessitating mutual strategies across all European countries. So far, mandatory vaccination policies have shown the most potential in achieving high and sustainable influenza vaccination rates among HCWs.